These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38670314)

  • 21. Expression, function and cooperating partners of protease-activated receptor type 3 in vascular endothelial cells and B lymphocytes studied with specific monoclonal antibody.
    Kalashnyk O; Petrova Y; Lykhmus O; Mikhalovska L; Mikhalovsky S; Zhukova A; Gnatenko D; Bahou W; Komisarenko S; Skok M
    Mol Immunol; 2013 Jul; 54(3-4):319-26. PubMed ID: 23352962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds.
    Soh UJ; Trejo J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):E1372-80. PubMed ID: 22106258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.
    Ní Ainle F; O'Donnell JS; Johnson JA; Brown L; Gleeson EM; Smith OP; Preston RJ
    J Biol Chem; 2011 Jan; 286(2):1323-30. PubMed ID: 21044954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.
    Bae JS; Yang L; Manithody C; Rezaie AR
    Blood; 2007 Dec; 110(12):3909-16. PubMed ID: 17823308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity.
    Stavenuiter F; Mosnier LO
    Blood; 2014 Nov; 124(23):3480-9. PubMed ID: 25320242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
    Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3.
    Guo H; Liu D; Gelbard H; Cheng T; Insalaco R; Fernández JA; Griffin JH; Zlokovic BV
    Neuron; 2004 Feb; 41(4):563-72. PubMed ID: 14980205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated protein C.
    Griffin JH; Fernández JA; Gale AJ; Mosnier LO
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():73-80. PubMed ID: 17635713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.
    Sinha RK; Wang Y; Zhao Z; Xu X; Burnier L; Gupta N; Fernández JA; Martin G; Kupriyanov S; Mosnier LO; Zlokovic BV; Griffin JH
    Blood; 2018 Mar; 131(11):1163-1171. PubMed ID: 29343482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAR1-stimulated platelet releasate promotes angiogenic activities of endothelial progenitor cells more potently than PAR4-stimulated platelet releasate.
    Huang Z; Miao X; Luan Y; Zhu L; Kong F; Lu Q; Pernow J; Nilsson G; Li N
    J Thromb Haemost; 2015 Mar; 13(3):465-76. PubMed ID: 25495701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
    Riewald M; Ruf W
    J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.
    Martínez de Lizarrondo S; Roncal C; Calvayrac O; Rodríguez C; Varo N; Purroy A; Lorente L; Rodríguez JA; Doeuvre L; Hervás-Stubbs S; Angles-Cano E; Páramo JA; Martínez-González J; Orbe J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1477-87. PubMed ID: 22492089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes.
    Madhusudhan T; Wang H; Straub BK; Gröne E; Zhou Q; Shahzad K; Müller-Krebs S; Schwenger V; Gerlitz B; Grinnell BW; Griffin JH; Reiser J; Gröne HJ; Esmon CT; Nawroth PP; Isermann B
    Blood; 2012 Jan; 119(3):874-83. PubMed ID: 22117049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Podocyte Integrin-
    Madhusudhan T; Ghosh S; Wang H; Dong W; Gupta D; Elwakiel A; Stoyanov S; Al-Dabet MM; Krishnan S; Biemann R; Nazir S; Zimmermann S; Mathew A; Gadi I; Rana R; Zeng-Brouwers J; Moeller MJ; Schaefer L; Esmon CT; Kohli S; Reiser J; Rezaie AR; Ruf W; Isermann B
    J Am Soc Nephrol; 2020 Aug; 31(8):1762-1780. PubMed ID: 32709711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.
    Mosnier LO; Zampolli A; Kerschen EJ; Schuepbach RA; Banerjee Y; Fernández JA; Yang XV; Riewald M; Weiler H; Ruggeri ZM; Griffin JH
    Blood; 2009 Jun; 113(23):5970-8. PubMed ID: 19244160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C.
    Huuskonen MT; Wang Y; Nikolakopoulou AM; Montagne A; Dai Z; Lazic D; Sagare AP; Zhao Z; Fernandez JA; Griffin JH; Zlokovic BV
    J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34846535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell painting with an engineered EPCR to augment the protein C system.
    Bouwens EA; Stavenuiter F; Mosnier LO
    Thromb Haemost; 2015 Nov; 114(6):1144-55. PubMed ID: 26272345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.
    Bouwens EA; Stavenuiter F; Mosnier LO
    J Thromb Haemost; 2013 Jun; 11 Suppl 1(0 1):242-53. PubMed ID: 23809128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin.
    Biswas I; Giri H; Panicker SR; Rezaie AR
    Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):603-616. PubMed ID: 38174561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.